Join

Compare · TLIS vs WAT

TLIS vs WAT

Side-by-side comparison of Talis Biomedical Corporation (TLIS) and Waters Corporation (WAT): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both TLIS and WAT operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
  • WAT is the larger of the two at $30.42B, about 209.6x TLIS ($145.1M).
  • WAT has hit the wire 8 times in the past 4 weeks while TLIS has been quiet.
  • WAT has more recent analyst coverage (25 ratings vs 5 for TLIS).
MetricTLISWAT
Company
Talis Biomedical Corporation
Waters Corporation
Price
$4.41+6.78%
$309.80-0.45%
Market cap
$145.1M
$30.42B
1M return
+0.00%
-
1Y return
+0.00%
-
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NASDAQ
NYSE
IPO
2021
1995
News (4w)
0
8
Recent ratings
5
25
TLIS

Talis Biomedical Corporation

Talis Biomedical Corporation operates as a molecular diagnostic company. It is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. The company is also developing Talis One assay kits for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B plus SARS-CoV-2. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

WAT

Waters Corporation

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.